WINTER SPRINGS, Fla., July 28. 28, 2022 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (IRMD) announced today that the company will release its second quarter 2022 financial results before market open on Friday, July 29.e. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss these results and answer questions.

IRADIMED has scheduled a conference call to discuss this announcement beginning at 11:00 a.m. Eastern Time today, July 29, 2022. Those interested in participating in the conference call can do so by registering here https://register.vevent.com/register/BI3271df296f5d41f5a8b888dee69b451c.
Once registered, a call number and a unique PIN will be provided to connect.

The conference call will also be available in real time via the Internet at https://edge.media-server.com/mmc/p/3y35zjak. A recording of the call will be available on the Company’s website once the call is complete.


IRADIMED CORPORATION is a leader in the development of innovative magnetic resonance imaging (“MRI”) compatible medical devices. We are the only known supplier of a non-magnetic intravenous (“IV”) infusion pump system specifically designed for safe use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components that can create radio frequency interference and are dangerous to use in the presence of the strong magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system was engineered with a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts and other special features to safely and predictably deliver anesthesia and therapy. other IV fluids during various MRI procedures. Our pump solution offers a seamless approach that enables precise, safe and reliable fluid delivery before, during and after an MRI, which is important for critically ill patients who cannot be removed from life-saving medications, and children and infants who usually need to be sedated. remain still during an MRI.

Our 3880 MRI Compatible Patient Vital Signs Monitoring System was designed with non-magnetic components and other special features to safely and accurately monitor a patient’s vital signs during various MRI procedures. The IRADIMED 3880 system operates reliably in magnetic fields up to 30,000 gauss, meaning it can operate virtually anywhere in the MRI scanner room. The IRADIMED 3880 has a compact and lightweight design allowing it to travel with the patient from their ICU, to MRI and back, improving patient safety through uninterrupted monitoring of vital signs and reducing the length of stay for seriously ill patients. critical care units. IRADIMED 3880 features include: Wireless ECG with dynamic gradient filtering; Wireless SpO2 using Masimo® algorithms; non-magnetic breathing CO2; invasive and non-invasive blood pressure; the patient’s temperature, and; optional advanced multi-gas anesthetic agent unit with continuous minimum alveolar concentration measurements. The IRADIMED 3880 MRI Compatible Patient Vital Signs Monitoring System has an easy-to-use design and enables efficient communication of patient vital signs information to clinicians.

Please visit www.iradim.com for more information.

Media Contact:
John “Jack” Glenn
Financial director
(407) 677-8022
[email protected]


Comments are closed.